Photocure Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 102

Employees

  • Stock Symbol
  • PHO

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $4.48
  • (As of Friday Closing)

Photocure General Information

Description

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Hoffsveien 4
  • 0275 Oslo
  • Norway
+47 22
Primary Industry
Pharmaceuticals
Other Industries
Other Devices and Supplies
Stock Exchange
OSL
Vertical(s)
Corporate Office
  • Hoffsveien 4
  • 0275 Oslo
  • Norway
+47 22

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Photocure Stock Performance

As of 13-Nov-2026, Photocure’s stock price is $4.48. Its current market cap is $121M with 27M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.48 $4.38 $4.34 - $8.24 $121M 27M 73.8K $0.19

Photocure Financials Summary

As of 30-Sep-2026, Photocure has a trailing 12-month revenue of $70.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 124,081 164,461 122,314 154,106
Revenue 70,600 51,183 48,739 47,266
EBITDA 13,636 2,424 4,857 4,913
Net Income 5,006 (146) (310) 92
Total Assets 91,564 70,262 65,189 70,004
Total Debt 0 1,029 2,332 2,752
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Photocure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Photocure‘s full profile, request access.

Request a free trial

Photocure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, mark
Pharmaceuticals
Oslo, Norway
102 As of 2025

Basel, Switzerland
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Photocure Competitors (4)

One of Photocure’s 4 competitors is Novartis, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland
Evonile Pharma Private Equity-Backed Mumbai, India
Sanofi Corporation Gentilly, France
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
To view Photocure’s complete competitors history, request access »

Photocure Patents

Photocure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026052815-A1 Use of hal in a method for predicting bladder cancer immunotherapy response Pending 05-Sep-2024
EP-4804913-A1 Method and system for automated guided laser coagulation Pending 09-Nov-2023
WO-2025099327-A1 Method and system for automated guided laser coagulation Inactive 09-Nov-2023
AU-2024231397-A1 Therapy for bladder cancer Pending 07-Mar-2023
EP-4676462-A1 Therapy for bladder cancer Pending 07-Mar-2023 A61K31/221
To view Photocure’s complete patent history, request access »

Photocure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Photocure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Photocure‘s full profile, request access.

Request a free trial

Photocure Acquisitions (1)

Photocure’s most recent deal was a Merger/Acquisition with Vesica Health for . The deal was made on 01-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vesica Health 01-Jun-2026 Merger/Acquisition Diagnostic Equipment
To view Photocure’s complete acquisitions history, request access »

Photocure ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

27.14 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Pharmaceuticals

Subindustry

of 438

Rank

Percentile

To view Photocure’s complete esg history, request access »

Photocure Exits (1)

Photocure’s most recent exit was on 01-Jun-2026 from Vesica Health. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Vesica Health 01-Jun-2026 Completed
To view Photocure’s complete exits history, request access »

Photocure Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Vesica Health Princeton, NJ 2022

Photocure FAQs

  • When was Photocure founded?

    Photocure was founded in 1997.

  • Where is Photocure headquartered?

    Photocure is headquartered in Oslo, Norway.

  • What is the size of Photocure?

    Photocure has 102 total employees.

  • What industry is Photocure in?

    Photocure’s primary industry is Pharmaceuticals.

  • Is Photocure a private or public company?

    Photocure is a Public company.

  • What is Photocure’s stock symbol?

    The ticker symbol for Photocure is PHO.

  • What is the current stock price of Photocure?

    As of 13-Nov-2026 the stock price of Photocure is $4.48.

  • What is the current market cap of Photocure?

    The current market capitalization of Photocure is $121M.

  • What is Photocure’s current revenue?

    The trailing twelve month revenue for Photocure is $70.6M.

  • Who are Photocure’s competitors?

    Novartis, Evonile Pharma, Sanofi, and AstraZeneca are competitors of Photocure.

  • What is Photocure’s annual earnings per share (EPS)?

    Photocure’s EPS for 12 months was $0.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process